Share on LinkedInShare on LinkedIn

ARTICLE · 16 JUNE 2020

SEC Charges Trader For COVID-19 "Pump And Dump" Scheme

Hogan Lovells Cadwalader
Hogan Lovells Cadwalader
Contributor
Hogan Lovells Cadwalader

Hogan Lovells Cadwalader

Hogan Lovells Cadwalader is a global law firm trusted by clients to deliver on complex, high-stakes...

View firm profile
Explore more from Hogan Lovells Cadwalader

The SEC charged a California penny stock trader for engaging in a COVID-19 testing "pump and dump" scheme.

United StatesCorporate/Commercial Law

The SEC charged a California penny stock trader for engaging in a COVID-19 testing "pump and dump" scheme.

In a Complaint filed in the U.S. District Court for the Northern District of California, the SEC alleged that the trader made hundreds of "false and misleading" statements on an online forum in an effort to get others to invest in a biotechnology company. The SEC alleged that the trader made claims that the company had developed a blood test for COVID-19, without disclosing that he owned a large amount of the company's stock or that he planned to sell his shares. The SEC further alleged that the trader used "spoofing," a technique of deception in which the trader places and then cancels, significant orders of the company's stock to falsely portray a high demand for the security. According to the SEC, the trader's deceptive techniques were successful, as the trader ultimately received "substantial monetary gains" from investors.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from